These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10901337)

  • 41. Progesterone co-administration in patients discontinuing long-term benzodiazepine therapy: effects on withdrawal severity and taper outcome.
    Schweizer E; Case WG; Garcia-Espana F; Greenblatt DJ; Rickels K
    Psychopharmacology (Berl); 1995 Feb; 117(4):424-9. PubMed ID: 7604143
    [TBL] [Abstract][Full Text] [Related]  

  • 42. In-patient benzodiazepine withdrawal: comparison of fixed and symptom-triggered taper methods.
    McGregor C; Machin A; White JM
    Drug Alcohol Rev; 2003 Jun; 22(2):175-80. PubMed ID: 12850904
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pregabalin long-term treatment and assessment of discontinuation in patients with generalized anxiety disorder.
    Kasper S; Iglesias-García C; Schweizer E; Wilson J; DuBrava S; Prieto R; Pitman VW; Knapp L
    Int J Neuropsychopharmacol; 2014 May; 17(5):685-95. PubMed ID: 24351233
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A lecithin phosphatidylserine and phosphatidic acid complex (PAS) reduces symptoms of the premenstrual syndrome (PMS): Results of a randomized, placebo-controlled, double-blind clinical trial.
    Schmidt K; Weber N; Steiner M; Meyer N; Dubberke A; Rutenberg D; Hellhammer J
    Clin Nutr ESPEN; 2018 Apr; 24():22-30. PubMed ID: 29576358
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term benzodiazepine users 3 years after participation in a discontinuation program.
    Rickels K; Case WG; Schweizer E; Garcia-Espana F; Fridman R
    Am J Psychiatry; 1991 Jun; 148(6):757-61. PubMed ID: 2035717
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Double-blind clinical assessment of alprazolam, a new benzodiazepine derivative, in the treatment of moderate to severe anxiety.
    Greiss KC; Fogari R
    J Clin Pharmacol; 1980; 20(11):693-9. PubMed ID: 6112245
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Double-blind study of alprazolam, diazepam, clonidine, and placebo in the alcohol withdrawal syndrome: preliminary findings.
    Adinoff B
    Alcohol Clin Exp Res; 1994 Aug; 18(4):873-8. PubMed ID: 7978098
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predictors of long-term benzodiazepine abstinence in participants of a randomized controlled benzodiazepine withdrawal program.
    Voshaar RC; Gorgels WJ; Mol AJ; van Balkom AJ; Mulder J; van de Lisdonk EH; Breteler MH; Zitman FG
    Can J Psychiatry; 2006 Jun; 51(7):445-52. PubMed ID: 16838826
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Personality and symptom sensitivity predictors of alprazolam withdrawal in panic disorder.
    Roy-Byrne P; Russo J; Pollack M; Stewart R; Bystrisky A; Bell J; Rosenbaum J; Corrigan MH; Stolk J; Rush AJ; Ballenger J
    Psychol Med; 2003 Apr; 33(3):511-8. PubMed ID: 12701671
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical pharmacology, clinical efficacy, and behavioral toxicity of alprazolam: a review of the literature.
    Verster JC; Volkerts ER
    CNS Drug Rev; 2004; 10(1):45-76. PubMed ID: 14978513
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Randomized clinical trial of supervised tapering and cognitive behavior therapy to facilitate benzodiazepine discontinuation in older adults with chronic insomnia.
    Morin CM; Bastien C; Guay B; Radouco-Thomas M; Leblanc J; Vallières A
    Am J Psychiatry; 2004 Feb; 161(2):332-42. PubMed ID: 14754783
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antidepressants for the treatment of generalized anxiety disorder. A placebo-controlled comparison of imipramine, trazodone, and diazepam.
    Rickels K; Downing R; Schweizer E; Hassman H
    Arch Gen Psychiatry; 1993 Nov; 50(11):884-95. PubMed ID: 8215814
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The efficacy of pregabalin and benzodiazepines in generalized anxiety disorder presenting with high levels of insomnia.
    Montgomery SA; Herman BK; Schweizer E; Mandel FS
    Int Clin Psychopharmacol; 2009 Jul; 24(4):214-22. PubMed ID: 19542983
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Multicenter double-blind efficacy and safety study comparing alprazolam, diazepam and placebo in clinically anxious patients.
    Cohn JB
    J Clin Psychiatry; 1981 Sep; 42(9):347-51. PubMed ID: 6115853
    [TBL] [Abstract][Full Text] [Related]  

  • 55. What are the issues surrounding long-term benzodiazepine treatment for generalized anxiety disorder.
    Lapierre YD
    J Psychiatry Neurosci; 1998 Jan; 23(1):80. PubMed ID: 11505959
    [No Abstract]   [Full Text] [Related]  

  • 56. Changes in "withdrawal symptoms" following discontinuation of low-dose diazepam.
    Hayward P; Wardle J; Higgitt A; Gray J
    Psychopharmacology (Berl); 1996 Jun; 125(4):392-7. PubMed ID: 8826545
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A prospective treatment study of premenstrual symptoms using a triphasic oral contraceptive.
    Graham CA; Sherwin BB
    J Psychosom Res; 1992 Apr; 36(3):257-66. PubMed ID: 1564678
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Review of the side-effect profile of buspirone.
    Newton RE; Marunycz JD; Alderdice MT; Napoliello MJ
    Am J Med; 1986 Mar; 80(3B):17-21. PubMed ID: 2870641
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A double-blind comparison of the effects of gradual withdrawal of lorazepam, diazepam and bromazepam in benzodiazepine dependence.
    Murphy SM; Tyrer P
    Br J Psychiatry; 1991 Apr; 158():511-6. PubMed ID: 1675901
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A therapeutic and discontinuation study of clobazam and diazepam in anxiety neurosis.
    Lapierre YD; Tremblay A; Gagnon A; Monpremier P; Berliss H; Oyewumi LK
    J Clin Psychiatry; 1982 Sep; 43(9):372-4. PubMed ID: 6126475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.